Recap: Humana Q2 Earnings - Benzinga
Shares of Humana (NYSE:HUM) were unchanged after the company reported Q2 results.
Quarterly Results
Earnings per share fell 45.14% over the past year to $6.89, which beat the estimate of $6.82.
Revenue of $20,582,000,000 higher by 7.86% from the same period last year, which beat the estimate of $20,520,000,000.
Outlook
The upcoming fiscal year's EPS expected to be between $21.25 and $21.75.
Details Of The Call
Date: Jul 28, 2021
Time: 09:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/zfbz6cqy
Price Action
52-week high: $475.44
Company's 52-week low was at $370.22
Price action over last quarter: Up 4.44%
Company Overview
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.
Comments
Post a Comment